Brian I. Rini, MD
Advertisement
Articles by Brian I. Rini, MD
Advertisement
Latest Updated Articles
Relapsed/Refractory Clear Cell RCC: Novel Treatment StrategiesPublished: July 17th 2023 | Updated:
Dr. Rini on Choosing Between IO/IO or IO/TKI Combinations in mRCCPublished: November 6th 2020 | Updated:
- Dosing Strategies With First-Line Therapy in Advanced Clear Cell RCC
Published: July 3rd 2023 | Updated:
Future Outlooks in the Treatment of Advanced RCCPublished: December 27th 2023 | Updated:
Factors in Selecting First-Line Therapy for Patients With Advanced Clear Cell RCCPublished: June 26th 2023 | Updated:
Dr. Rini on the Results of an Exploratory Analysis of the IMmotion151 Trial in mRCCPublished: May 17th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5